Articles From: Asia stocks fall; Shanghai and Sydney lead retreat to AstraZeneca, AT&T, Campbell Soup fall


2014/5/19
By Laura He, MarketWatch HONG KONG (MarketWatch) -- Asian stocks ended mostly lower on Monday, with mainland China and Australia leading losses.
Sign-up for Asia stocks fall; Shanghai and Sydney lead retreat investment picks
2014/5/13
By Laura He and Michael Kitchen, MarketWatch HONG KONG (MarketWatch) -- Asia stocks were mostly higher on Tuesday, tracking overnight gains in the U.S., while Shanghai markets slipped as China's April economic data slightly missed expectations.
Sign-up for Asia stocks mostly higher after China data investment picks
2014/5/2
By Laura He and Michael Kitchen, MarketWatch HONG KONG (MarketWatch) -- Asian stocks were mostly higher on Friday, as markets awaited the U.S. jobs report for April due out later in the day.
Sign-up for Asia stocks mostly higher ahead of U.S. jobs report investment picks
2014/5/22
By Laura He and Michael Kitchen, MarketWatch HONG KONG (MarketWatch) -- Asian stocks rallied on Thursday, bolstered by better-than-expected Chinese manufacturing PMI data and overnight gains on Wall Street.
Sign-up for Asia stocks rally after China data, U.S. gains investment picks
2014/5/5
By Laura He and Michael Kitchen, MarketWatch HONG KONG (MarketWatch) -- Asia stocks came under pressure on Monday after HSBC released a disappointing final reading on China's manufacturing activity in April, adding to concerns of a slowdown in the world's second-largest economy.
Sign-up for Asia stocks: China data weigh on market investment picks
By Mia Lamar and Daniel Inman Stocks in Hong Kong fell on signs of further contraction in China's manufacturing sector, while a rally on Wall Street bolstered Japan in a quiet, holiday-shortened week for regional markets.
Sign-up for Asian shares end mixed investment picks
2014/4/25
By Daniel Inman South Korean stocks fell and Japanese stocks were flat early Friday, as Tokyo was held back by a firmer yen, as investors focused on a flurry of earnings reports.
Sign-up for Asian shares lackluster as Tokyo looks to earnings investment picks
2014/5/1
By Laura He, MarketWatch HONG KONG (MarketWatch) -- Japan markets rallied on upbeat corporate earnings on Thursday, while miners and financial stocks led Australia's benchmark stock index lower.
Sign-up for Asian shares mixed, with Japan up on earnings investment picks
2014/5/20
By Laura He and Michael Kitchen, MarketWatch HONG KONG (MarketWatch) -- Asian stocks ended mixed on Tuesday, with Japan breaking a four-day losing streak.
Sign-up for Asian stocks close mixed; Japan snaps losing streak investment picks
2014/5/23
By Laura He, MarketWatch HONG KONG (MarketWatch) -- Asian stocks were mostly higher on Friday, following a positive U.S. lead, while Thai markets fell after the country's military took control in a coup.
Sign-up for Asian stocks mostly up; Thai markets fall after coup investment picks
2014/5/8
By Laura He and Michael Kitchen, MarketWatch HONG KONG (MarketWatch) -- Asian stocks rose on Thursday, bolstered by positive Chinese trade data and upbeat comments from Federal Reserve Chairwoman Janet Yellen about the U.S. economic outlook.
Sign-up for Asian stocks rise, helped by Chinese data investment picks
2014/07/14
Waddell & Reed is struggling with atypical portfolio manager departures, but this doesn't change our valuation.
Sign-up for Asset Manager's Revolving Door Spins Once More investment picks
2014/4/29
Same Community Revenue Growth of 3.1% Same Community Average Occupancy of 96.2% Portfolio Transformation Continues with Property Sales CLEVELAND , April 29, 2014 /PRNewswire/ -- Associated Estates Realty Corporation (NYSE, NASDAQ: AEC) announced today its financial results for the first quarter ended March 31 , 2014.
Sign-up for Associated Estates Realty Corporation Reports First Quarter 2014 Results investment picks
Assured Guaranty Ltd.
Sign-up for Assured Guaranty Ltd. Declares Quarterly Dividend of $0.11 per Common Share investment picks
Assured Guaranty Ltd.
Sign-up for Assured Guaranty Ltd. to Report First Quarter 2014 Financial Results on May 8, 2014 investment picks
ENGLEWOOD CLIFFS, N.J., May 5, 2014 (GLOBE NEWSWIRE) -- Asta Funding, Inc. (Nasdaq:ASFI) , a receivable asset management and liquidation firm, will report its financial results for the second quarter and six months of fiscal year 2014, the period ended March 31, 2014, before the markets open on Thursday, May 8, 2014.
Sign-up for Asta Funding, Inc. to Report Second Quarter and Six Months Results of Fiscal Year 2014 investment picks
HORSHAM, Pa.
Sign-up for Astea International to Webcast First Quarter 2014 Results investment picks
HORSHAM, Pa.
Sign-up for Astea Reports First Quarter 2014 Results investment picks
CHATTANOOGA, Tenn., April 22, 2014 (GLOBE NEWSWIRE) -- Astec Industries, Inc. (Nasdaq:ASTE) today reported results for their first quarter ended March 31, 2014.
Sign-up for Astec Industries Reports First Quarter 2014 Results investment picks
CHATTANOOGA, Tenn., April 15, 2014 (GLOBE NEWSWIRE) -- You are invited by Astec Industries, Inc. (Nasdaq:ASTE) to participate in a conference call to review its First Quarter financial results.
Sign-up for Astec Industries, Inc. Announces Its First Quarter Conference Call April 22, 2014 at 10:00 A.M. Eastern Time investment picks
TOKYO and SAN FRANCISCO , May 6, 2014 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) and Medivation Inc. (NASDAQ: MDVN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the supplemental New Drug Application (sNDA) to extend the indication for XTANDI® (enzalutamide) capsules for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC) who have not received chemotherapy.
Sign-up for Astellas and Medivation Receive Priority Review from FDA for XTANDI® (Enzalutamide) Capsules In Chemotherapy-Naive Advanced Prostate Cancer investment picks
2014/5/19
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- European stock markets moved lower on Monday, with AstraZeneca PLC leading the charge south after rejecting a sweetened Pfizer offer, while mining firms declined on the back of further signs of a slowdown in the Chinese housing market.
Sign-up for AstraZeneca bruises Stoxx 600 after it rejects Pfizer investment picks
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- AstraZeneca PLC shares fronted gains for U.K. equities Monday, bolstered by renewed prospects for a Pfizer Inc. takeover of the British drug maker.
Sign-up for AstraZeneca jumps, leading U.K. stocks higher investment picks
LONDON (MarketWatch) -- AstraZeneca PLC's (uk:azn) [s:azn] board on Friday rejected a sweetened acquisition bid from Pfizer Inc. (PFE), saying financial and other terms of the offer were "inadequate." Pfizer earlier on Friday raised its bid for AstraZeneca to GBP50 ($84.47) a share, up from an earlier offer of GBP46.61 a share, or about $100 billion.
Sign-up for AstraZeneca rebuffs Pfizer's sweetened merger offer investment picks
2014/5/19
By Ian Walker LONDON --
Sign-up for AstraZeneca rejects higher 'final' offer from Pfizer investment picks
By Hester Plumridge, Jonathan D.
Sign-up for AstraZeneca rejects Pfizer bid as inadequate investment picks
MADRID (MarketWatch) -- AstraZeneca PLC (AZN)(uk:azn) on Monday rejected a final offer made by Pfizer Inc. (PFE) for its rival.
Sign-up for AstraZeneca rejects Pfizer's final proposal, says undervalues company investment picks
2014/4/24
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- U.K.'s FTSE 100 index headed for its highest close in almost seven weeks on Thursday, with Anglo American and AstraZeneca leading stocks higher after well-received trading updates.
Sign-up for AstraZeneca, Anglo American push FTSE to 7-week high investment picks
By Saumya Vaishampayan, MarketWatch NEW YORK (MarketWatch) -- Shares of AstraZeneca PLC, AT&T Inc., and Campbell Soup Co.
Sign-up for AstraZeneca, AT&T, Campbell Soup fall investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Asia stocks fall; Shanghai and Sydney lead retreat to AstraZeneca, AT&T, Campbell Soup fall
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry